Stomach News and Research

RSS

FDA clears Cook Medical's Evolution Duodenal Controlled-Release Stent

Cook Medical announced today that its Evolution Duodenal Controlled-Release Stent was recently granted 510(k) clearance by the Food & Drug Administration.

18 Oct 2011

One in six mobile phones home for E. coli: Study

The London's School of Hygiene and Tropical Medicine released a study in conjunction with the Queen Mary, University of London which suggests that Britons are not doing a good enough job of washing hands. Experts said the most likely reason for the potentially harmful bacteria festering on so many gadgets was people failing to wash their hands properly with soap after going to the toilet.

17 Oct 2011

Six new Bristol-Myers Squibb grants to reduce cancer disparities in CEE

The Bristol-Myers Squibb Foundation today announced six new grants totaling more than $900,000 that focus on improving cancer awareness, prevention and care by developing cancer nursing skills and building nurse-community partnerships in Hungary, Poland, Romania and Russia.

15 Oct 2011

One in six mobile phones in the UK is contaminated with fecal bacteria

One in six mobile phones in Britain is contaminated with faecal matter, according to new research released ahead of Global Handwashing Day.

14 Oct 2011

SFDA approves China Medical Technologies' colorectal cancer assay

China Medical Technologies, Inc., a leading China-based advanced in-vitro diagnostic company, today announced that China's State Food and Drug Administration has approved the Company's real-time PCR-based V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog assay as a companion diagnostic test for the use of a targeted drug for the treatment of colorectal cancer patients.

13 Oct 2011

Aspirin desensitization procedure can benefit patients with sinusitis, asthma and AERD

Beth Moore can now keep up with her children. The suburban Philadelphia mother of two had suffered from allergies and chronic sinusitis since her teens. With age her symptoms became more severe, turning into bronchitis and eventually asthma, diminishing her ability to breathe and sapping her of her energy. The only complete relief came from aspirin; and the aspirin desensitization that allowed her to overcome her aspirin allergy and end her decades-long battle with sinusitis.

11 Oct 2011

Rare and severe hypoglycemia could be genetic

The life-threatening condition depicts the fact that the body does not have enough energy to function. Scientists at the University of Cambridge say mutations in the AKT2 gene are to blame. Writing in the journal Science, they say there are already cancer drugs which target a similar process.

10 Oct 2011

Merck’s diabetes combo pill gets FDA nod

The U.S. Food and Drug Administration (FDA) has approved Merck & Co.’s Juvisync diabetes drug, a combination pill for type 2 diabetes. Juvisync combines two Merck drugs already on the market, 1) glucose-lowering Januvia (Sitagliptin) medication and 2) cholesterol-lowering Zocor (Simvastatin).

10 Oct 2011

Loyola surgeon performs minimally invasive emergency procedure to repair AAA

Jack Kory of Mokena, Il. was eating his breakfast oatmeal when he suddenly felt the worst pain in his life. The searing pain came on suddenly in his stomach and spread to his knees. It was caused by an abdominal aortic aneurysm (AAA) that had suddenly burst, causing massive internal bleeding. Traditionally, few patients have survived such ruptures. But Loyola University Medical Center vascular surgeon Dr. Richard Hershberger was able to repair Kory's aneurysm with a minimally invasive emergency procedure.

10 Oct 2011

First combination drug to treat type 2 diabetes and high cholesterol receives FDA approval

The U.S. Food and Drug Administration today approved Juvisync (sitagliptin and simvastatin), a fixed-dose combination (FDC) prescription medication that contains two previously approved medicines in one tablet for use in adults who need both sitagliptin and simvastatin.

7 Oct 2011

Researchers develop mouse model to examine role of bone marrow-derived cells

Bone marrow-derived cells (BMDCs) participate in the growth and spread of tumors of the breast, brain, lung, and stomach. To examine the role of BMDCs, researchers developed a mouse model that could be used to track the migration of these cells while tumors formed and expanded.

7 Oct 2011

Scientists discover rare genetic alteration responsible for hypoglycaemia

Cambridge scientists have identified the cause of a rare, life-threatening form of hypoglycaemia. Their findings, which have the potential to lead to pharmaceutical treatments for the disorder, were published today, 07 October, in the journal Science.

7 Oct 2011

Study shows Sox2 expression in many adult stem cells

Investigators at the Massachusetts General Hospital (MGH) Center for Regenerative Medicine and the Harvard Stem Cell Institute (HSCI) have found that Sox2 - one of the transcription factors used in the conversion of adult stem cells into induced pluripotent stem cells (iPSCs) - is expressed in many adult tissues where it had not been previously observed.

7 Oct 2011

Viewpoints: Jobs and 'Obamacare;' jurisdictional barriers to health law challenges; reforming provider payment

By most of the usual measures, President Obama has no business being reelected. Here's why he might be anyway. On Wednesday morning, as Senate Democratic leaders were scrambling to find a way to enact part of Obama's jobs bill, a dozen Republican lawmakers assembled outside the Capitol to complain about ... health-care reform.

7 Oct 2011

Blue Shield of California refuses to pay for breast cancer drug Avastin

In a new development, health insurer Blue Shield of California has decided not to pay for Roche Holding's drug Avastin to treat breast cancer after health advisers said it was not safe or clinically beneficial. Blue Shield of California with around 3.3 million members, said in a notice posted on its web site that the drug would no longer be covered as a treatment for metastatic breast cancer beginning October 17. It said exceptions may be considered on a case-by-case basis.

4 Oct 2011

Men get type 2 diabetes at a lower BMI than women: Study

A latest study reveals that men need to gain little weight in order to develop type 2 diabetes as compared to women. A study carried out by clinical academics at Glasgow University found men developed the disease at a lower Body Mass Index than women, explaining why men have higher rates of diabetes in many parts of the world.

3 Oct 2011

APhA encourages patients to discuss with pharmacist about pain and medications

In honor of Pain Awareness Month, the American Pharmacists Association (APhA) encourages patients to have an open discussion with their pharmacist about their pain and the medications they take for pain.

30 Sep 2011

Bulgaria’s decades old anti-smoking pill could be a cheap and effective answer to smoking cessation

A pill from Bulgaria during the Soviet era shows promise for helping millions of smokers cheaply and safely kick the habit, the first big clinical trial of it shows. It is unclear whether it will ever reach the market in the U.S. or Western Europe though.

29 Sep 2011

Ibandronate controls pain in prostate cancer patients with bone metastases

Many prostate cancer patients develop bone metastases, and controlling the pain these cause can be difficult. Now the first large randomised Phase III trial of a bisphosphonate drug in these patients has shown that a single dose of the drug is as good for pain relief as single dose radiotherapy, the standard treatment for bone metastases. Results of the trial were presented at the 2011 European Multidisciplinary Cancer Congress.

26 Sep 2011

ASU scientists receive USDA grants to combat food-related illness

Roughly 1 in six Americans are sickened every year by food-borne ailments, according to the Centers for Disease Control and Prevention. The effects of these illnesses range from acutely unpleasant to lethal, and the problem may be getting worse, as our food supply becomes more global, with an increasing number of antibiotic-resistant pathogens.

21 Sep 2011